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ABSTRACT

ARTICLE HISTORY

Blood pressure (BP) control is a key target for interventions to reduce cognitive decline. This
cross-sectional study explored associations between objective (24-hour urine excretion) and subjective (food frequency questionnaire [FFQ]) measures of dietary sodium and nitrate intakes with
cognitive function and resting BP in the InCHIANTI cohort. Baseline data from 989 participants
aged >50 years were included. In fully adjusted models, participants with concurrent high nitrate
and low sodium (Odds Ratio (OR)¼0.49, 95%CI 0.32–0.76, p ¼ 0.001) and high nitrate and high
sodium (OR ¼ 0.49, 95%CI 0.32–0.77, p ¼ 0.002) 24-hour urinary concentrations had lower odds
of high BP than participants with low nitrate and high sodium concentrations. We found no significant associations between sodium and nitrate intakes (24-hour urinary concentrations and
FFQ) and poor cognitive performance. Urinary nitrate excretion was associated with lower BP
and results appeared to be independent of sodium intake. Further analyses in longitudinal studies are required to substantiate these findings.
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Introduction
Blood pressure (BP) control has emerged as a key target for long-term, effective interventions to reduce
cognitive decline and prevent dementia (Hughes et al.
2020). Hypertension in mid-life has been associated
with increased dementia risk (Livingston et al. 2020),
with a recent clinical trial reporting a lower risk of
mild cognitive impairment among individuals randomised to an intensive BP reduction intervention
(Williamson et al. 2019). However, data on the
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association of BP control with cognitive decline are
inconsistent in older individuals.
Dietary sodium (salt) and inorganic nitrate both
influence BP control (Strazzullo et al. 2009; Lundberg
et al. 2011). Epidemiological studies have reported
associations of high sodium diets with impaired BP
control and increased cardiovascular risk (Strazzullo
et al. 2009; Mente et al. 2018); this evidence has been
confirmed in several clinical trials demonstrating the
protective effects of salt reduction on cardiovascular
health (He et al. 2013; He and MacGregor 2018).

CONTACT Mario Siervo
mario.siervo@nottingham.ac.uk
School of Life Sciences, University of Nottingham, Nottingham, UK
Supplemental data for this article can be accessed at https://doi.org/10.1080/09637486.2021.1993157.
ß 2021 The Author(s). Published with license by Taylor and Francis Group, LLC
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

2

A. M. MCGRATTAN ET AL.

Dietary nitrate is an exogenous source for the
endogenous production of a substrate for, and metabolite of, nitric oxide (NO), which is known for its
multiple effects on physiological functions such BP,
neurovascular coupling, neurotransmission and
immunity (Clifford et al. 2019). Recent epidemiological studies and clinical trials have demonstrated
nitrate intake improves BP and metabolic health
(Babateen et al. 2018; Clifford et al. 2019).
While the scientific evidence for the benefits of dietary
sodium reduction and increased dietary nitrate intake on
BP appears robust, relatively little is known about the
association of both sodium and nitrate intake with cognitive decline. To date, a small number of epidemiological
studies among older adults have been conducted and
showed mixed associations between sodium intake and
cognitive performance (Fiocco et al. 2012; Haring et al.
2016; Rush et al. 2017; Nowak et al. 2018). The association of dietary nitrate with cognition is largely
unknown. A small number of clinical interventions have
been conducted reporting mixed results however, they
had overall a short duration and limited statistical power
(Stanaway et al. 2017; Clifford et al. 2019).
Nevertheless, with hypertension highlighted as an
important modifiable risk factor for dementia
(Livingston et al. 2020) and the consistent beneficial
effects of low sodium and high dietary nitrate intakes on
BP, it is relevant to investigate their independent and
combined putative associations with cognitive outcomes.
The consumption of a diet low in sodium and high in
nitrate could potentially represent a more effective dietary strategy to achieve greater reductions in BP and provide greater benefits in cognitive function. To our
knowledge, the interactive effects between dietary nitrate
and sodium intake are yet to be explored in humans.
In addition, the mixed results observed to date on
the associations of dietary nitrate and sodium intake
with health outcomes may be due to differences in
dietary assessment methods across studies. In particular, results could differ depending upon whether subjective, self-reported data measures of dietary intake
are utilised (e.g. food frequency questionnaire (FFQ)
or diet recall) compared with objective measures such
as 24-hour urinary sodium or nitrate concentrations
(Hill et al. 1996; Wielgosz et al. 2016). Inaccuracies,
inconsistencies, limited and/or poor-quality food composition tables to calculate dietary nitrate intake may
result in misreporting of nitrate intake. To our knowledge, a cross-validation analysis to evaluate associations
between
FFQ
and
24-hour
urinary
measurements of sodium and nitrate intake has not
been conducted.

The aim of this cross-sectional study was to explore
associations between objective (i.e. 24-hour urine
excretion) and subjective (i.e. self-reported FFQ)
measures of dietary sodium and nitrate intakes with
cognitive function and BP among older adults
(>50 years) from the InCHIANTI cohort. In addition,
this study aimed to conduct a cross-validation to
evaluate the comparability of measures of nitrate and
sodium intake derived from FFQ vs. 24-hour urine
concentrations.

Methods
Study population and setting
The InCHIANTI study is a population-based epidemiological investigation among an older adults living in the Chianti region in Tuscany, Italy. The details
of the study have been previously reported [18]. The
study was conducted by the Laboratory of Clinical
Epidemiology of the Italian National Institute of
Research and Care on Ageing (INRCA), Florence,
Italy. Ethical approval was granted by The INRCA
Ethical Committee. The InCHIANTI study aimed to
recruit older residents from two towns of the Chianti
area (Greve in Chianti and Bagno a Ripoli, Tuscany,
Italy) plus younger controls, and achieved a 91.6%
response rate at baseline (data collected between 1998
and 2000). 1453 individuals from 20 to 102 years of
age were randomly selected based on city registries [18].

Participant selection
For this cross-sectional analysis, we used data from
n ¼ 1270 participants older than 50 years at the baseline interview. In addition to age, the following exclusion criteria were applied: (1) total urine volume
<400 or >6000 ml; (2) total energy intake >800 and
<4000 kcal/day (Fiocco et al. 2012); (3) poor renal
function (eGFR < 30 ml/min). Following application
of exclusion criteria, the number of participants with
complete cognitive assessment data (Mini Mental
State Examination [MMSE]; Trail Making Task [TMT
A and TMT B] respectively) and BP measurements at
baseline varied within the dataset. Flowcharts of study
participants eligible for inclusion for each outcome
are illustrated in Figures 1(A–D) of the online supplementary material.
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Figure 1. Interactive effects of differences in 24-hour urinary concentrations of nitrate and sodium on mean systolic (A) and diastolic (B) resting blood pressure. Analysis of covariance was conducted to evaluate differences between the groups. Analyses were
adjusted for age, sex, disease count score (stroke, CHF, MI, PD, cancer and diabetes), BMI, physical activity, total energy intake,
smoking, kidney function and medication use (drugs for acid-related disorders; diuretics for CHF or hypertension; ACE inhibitors
(alone and in combination with diuretic); organic nitrates; aldosterone antagonists (diuretics); glucocorticoids for systemic use).

$¼Significant difference from LNLS and LNHS (p < 0.05). ¥ ¼ Significant difference from LNLS and LNHS (p < 0.05). Key: HNLS: high nitrate low sodium;
HNHS: high nitrate high sodium; LNLS: low nitrate low sodium; LNHS: low nitrate high sodium.

Blood pressure
Resting supine BP was measured in both arms using a
mercury sphygmomanometer. The sequence of measurements was right arm first, then a 2-minute pause,
then the left arm. Two further measurements were
subsequently carried out on the higher reading arm.
Systolic and diastolic BP were defined as the mean of
the second and third measurements. All BP measurements were taken from the initial baseline recruitment
examinations.
Cognitive function
Cognition was assessed at baseline using two measures: (1) an Italian version of the Mini Mental State
Examination (MMSE) (Folstein et al. 1975). MMSE
assesses global cognition including orientation, registration, attention, calculation, language and recall.
MMSE scores range from 0–30 with higher scores
indicating better cognitive function; (2) Trail Making
Test (TMT) (Reitan 1958). TMT was administered to
measure visuospatial scanning, sequential processing,
motor speed, attention, executive functioning and is
administered in two parts (TMT A and TMT B). In
TMT A, the participant was asked to draw lines to
connect circled numbers in a numerical sequence (i.e.
1-2-3, etc.), and in TMT B, participants were asked to
draw lines to connect numbers and letters in alternating order. TMT A and B was completed as quickly as
possible, and scores reflected the time needed to complete the task with 300 seconds as the maximum.
Higher scores indicated poorer performance. The

difference between TMT A and TMT B scores was
calculated to account for missing data in the completion of the TMT B test.
Dietary assessment measures
24-Hour urinary sodium
Sodium intake was estimated using the 24-hour
sodium urinary excretion. On the day of the study
visit, participants were provided with a plastic bottle
containing 1 g of boric acid as preservative, and
instructed to collect all the urine produced in the following 24 hours, making the maximum effort to avoid
dispersing urine during the collection period.
24-Hour urinary nitrate
Urinary nitrate concentration was estimated by the
24-hour nitrate urinary excretion and measured using
the spectrophotometric plate method which has been
described elsewhere (Smallwood et al. 2017). Briefly,
the assay reduces the nitrate in the sample to nitrite
which then forms a coloured chromogen upon reaction with the Griess reagent. Absorbance was read
using a plate reader at 540 nm. Thus, the assay does
not differentiate between nitrite and nitrate. As the
concentration of nitrate is approximately 1,000 times
that of nitrite in urine a ratio that at the very least
persists following nitrate supplementation we have
reported the results as urinary nitrate concentration
(Smallwood et al. 2017).
Dietary intake from FFQ. Usual dietary consumption
in the past year was assessed at baseline using a FFQ
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created for the European Prospective Investigation on
Cancer and Nutrition study and validated for the
InCHIANTI study (Pisani et al. 1997; Bartali et al.
2004). Daily sodium intake was calculated in mg/day.
Nitrate data is not included within national food composition tables; therefore a published comprehensive
database that includes the nitrate and nitrite concentrations in 3498 and 2134 individual food and beverages, respectively, was used to calculate dietary nitrate
intake (mg/day) (McMahon et al. 2017).
Covariates. Factors that were associated with cognitive function and BP in univariate analyses or known
to be associated from previous studies were considered as covariates in the analyses (Tanaka et al. 2018;
Clark et al. 2020). Sociodemographic covariates
included age (years), sex (male or female), and number of years of education. Height (m) and weight (kg)
were measured and used to calculate Body Mass
Index (BMI) (kg/m2). Total energy intake was assessed
using FFQ data (kcal/day). Lifestyle factors included
physical activity levels in the 12 months prior to participants’ baseline visit, assessed through a modified
standard interview-administered questionnaire and
coded into three categories of low activity (inactivity
or light-intensity activity <1 h per week), medium
activity (light-intensity activity 2–4 h per week), and
high physical activity (light-intensity activity at least
5 h per week or moderate activity at least 1–2 h per
week) (Wareham et al. 2002); smoking status was selfreported and categorised into never smokers, former
smokers or current smokers (smoking within 3 years
of interview); depressive symptoms were measured
using Centre for Epidemiological Studies Depression
(CESD) scores (0–60; higher scores related to greater
depressive symptoms). Use of medications (yes/no)
that may alter metabolism of sodium or nitrate in the
body were controlled for, including drugs for acid-

related disorders; diuretics for Congestive Heart
Failure (CHF) or hypertension; ACE inhibitors (alone
and in combination with diuretic); organic nitrates;
aldosterone antagonists (diuretics); glucocorticoids for
systemic use; antiepileptic; anti-Parkinson drugs; psycho-leptics: typical antipsychotics; psycho-leptics:
atypical antipsychotics; psycho-leptics: anxiolytics; psycho-analeptics: antidepressants; drugs for dementia.
Chronic diseases including, diabetes, ischaemic heart
disease, congestive heart failure, stroke, cancer,
Parkinson’s disease, were defined using standard clinical definitions which have been described previously
(Fabbri et al. 2015). For the analysis, a cumulative
count of the conditions present in each participant
was calculated as an indicator of general health status.
Estimated Glomerular Filtration Rate (eGFR) was estimated using the Cockcroft–Gault equation and used
to classify kidney function (Foundation 2002).
Data analysis. Statistical analyses were conducted
using IBM SPSS version 25.0 (New York, NY, USA).
The threshold for significance was set at p  0.05.
Descriptive statistics were summarised as mean and
SD or frequency and percentages. Histograms of the
distributions of 24-hour urinary sodium and nitrate
excretions and dietary sodium and nitrate intakes are
presented in Figure 2(A–D) of the online supplementary material. Scatter plots were produced to evaluate
the associations of measurements of nitrate and
sodium intake with 24-urinary excretion of nitrate
and sodium, respectively.
Multiple linear regression was used to investigate
the association between urinary sodium, urinary
nitrate, dietary sodium, and dietary nitrate with cognitive test scores and BP. Results are presented as estimate and standard error. Models were reported as
adjusted for age, sex, disease count, medication use,
BMI, physical activity, energy intake, smoking,

Figure 2. Scatter-plots showing the associations between 24-urinary sodium and nitrate concentrations with dietary sodium (A)
and nitrate (B) intake assessed by Food Frequency Questionnaire.
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education, depression, kidney function and BP (for
cognition analysis only). Normality of the residuals
distributions was checked to evaluate the fitness of the
regression models.
Logistic regression was used to calculate the odds
ratio (OR) for the association between urinary
sodium, urinary nitrate, dietary sodium and dietary
nitrate with poor cognitive performance and high BP.
Urinary nitrate, dietary nitrate, urinary sodium and
dietary sodium were stratified into tertiles based on
their frequency of distribution in the data set. Poor
MMSE cognitive performance was defined as a score
in the bottom 20th percentile of the population distribution for MMSE (Gross et al. 2019). According to
the time (in seconds) employed to perform each part
of the TMT, poor performance was defined as a score
in the 20th percentile of the population distribution as
higher scores demonstrate poorer performance (more
time taken to complete). BP was categorised according
to the European Society of Cardiology Guidelines
(Williams et al. 2018), with measurements for Systolic
BP (SBP) of 140 mmHg and/or Diastolic BP (DBP)
of 90 mmHg classed as high BP. Results are
expressed as ORs with 95% confidence intervals (CIs)
for poor cognitive performance/high BP with tertiles 2
and 3 compared with tertile 1 (lowest) of urinary or
dietary nitrate/sodium. Results from unadjusted and
fully adjusted models were reported. Covariates
included in the models were age, sex, disease count
score, medication use, BMI, physical activity, energy
intake, smoking, education, depression, kidney function and BP (for cognition analysis only). Normality
of the residuals distributions was checked to evaluate
the fitness of the regression models.
The interaction effect of intakes of sodium and
nitrate were assessed via logistic regression. Four
intake groups we created based on median values of
sodium (135 mmol/24 hr) and nitrate (667 mmol/
24 hr) urinary excretion (High intake ¼ above median
value; Low intake ¼ below median value), and reclassified into the following: Group 1, High Nitrate
and Low Sodium (HNLS); Group 2, High Nitrate and
High Sodium (HNHS); Group 3, Low Nitrate and
Low Sodium (LNLS) and Group 4, Low Nitrate
and High Sodium (LNHS) (reference group). The
same analysis process was followed as described previously to calculate the OR for the intake groups and
poor cognitive performance or high BP. Finally,
ANCOVA analyses were used to determine mean differences between the intake groups and, if significant,
post-hoc (Bonferroni) tests were conducted to identify
differences between dietary groups. ANCOVA
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analyses were adjusted for age, sex, disease count
score, medication use, BMI, physical activity, energy
intake, smoking, education, depression, kidney function and BP (for cognition analysis only).

Results
Participant characteristics
Table 1 shows the demographic and health characteristics
of the InCHIANTI participants included in this analysis.
The mean age of the sample was 73.5 years, with a higher
percentage being female (54.3%), married (63.2%) and
non-smokers (57.4%). The majority reported elementary
school as the highest level of education completed
(51.9%), followed by 27.6% who reported no schooling,
with a mean of 5.6 years of school completed across the
sample. On average, participants were overweight
(27.2 ± 4.1 kg/m2) and had a total daily energy intake of
1996 ± 602 kcal/day. The majority were moderately physically active (41.5%) and had relatively low CESD depression scores (12.8 ± 8.9). Most participants (61.2%) had no
comorbidities (including myocardial infarction, coronary
heart failure, stroke, cancer, Parkinson’s disease, or diabetes); 36.9% reported between 1 and 2 comorbidities.
On average, SBP was 145 ± 21 mmHg, DBP was
82 ± 9 mmHg and eGFR was 67 ± 20 mL/min across the
sample. For cognitive function, on average participants
scored 24.5 ± 5.2 on MMSE, 29.9 ± 16.5 seconds on TMT
A (n ¼ 889) and 28.9 ± 18.2 seconds on TMT B
(n ¼ 721). Urinary excretions of dietary nitrate and
sodium averaged at 862 ± 734 mmol/24 hr (median:
670.4 mmol/24 hr,
IQR:
650.2 mmol/24 hr)
and
139.5 ± 65.7 mmol/24 hr (median 134.5 mmol/24 hr, IQR:
75.2 mmol/24 hr), respectively. Intakes of dietary nitrate
and sodium as estimated by FFQ averaged at
89.0 ± 73.3 mg/day (median: 67.5 mg/day, IQR: 67.9 mg/
day) and 2358 ± 849 mg/day (median: 2266.4 mg/day,
IQR: 1014.2 mg/day), respectively.
Associations between sodium and nitrate intake
and cognitive function
Urinary sodium and dietary sodium intake were not
associated with any cognitive performance test scores
(MMSE, TMT A or TMT B) in unadjusted and fully
adjusted linear regression models. Similarly, for urinary nitrate and dietary nitrate, there were no associations with any cognitive function test scores (Table 2).
Associations between sodium and nitrate intake
and BP
Urinary sodium and dietary sodium intake were not
associated with BP (SBP or DBP). Urinary nitrate
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Table 1. Characteristics of InCHIANTI study participants aged
>50 years at baseline (n ¼ 989).
N
Age, years
Sex, men
Years of School (n ¼ 987)
Highest educational level completed
Nothing
Elementary
Secondary
High school
Professional school
University or equivalent
Undocumented educational level
Smoking status
Never smoked cigarettes
Former cigarette smoker
Current (within 3 years of interview)
Diabetes
Definite
Possible
Congestive heart failure
Definite
Possible
Stroke
Definite
Possible
TIA
Parkinson’s disease
Definite
Possible
Myocardial infarction
Definite
Possible
Cancer
Number of co-morbidities
(MI, CHF, stroke, cancer, PD, diabetes)
0
1–2
3–4
Systolic blood pressure, mmHg
Diastolic blood pressure, mmHg
Weight, kg
BMI, kg/m2 (n ¼ 982)
eGFR, mL/min
CESD Depression Score (n ¼ 884) (0–60)
Physical activity (n ¼ 861)
Low
Medium
High
Energy intake, kcal/day
Sodium, mg/day
Nitrate, mg/day (i ¼ 973)
Urinary sodium, mmol/24 hr (n ¼ 913)
Urinary nitrate mmol/24 hr (n ¼ 895)
Cognitive function
MMSE score (n ¼ 989)
TMT A score (n ¼ 889)
TMT B score (n ¼ 721)
TMT A–B (n ¼ 721)

Mean (SD)
or n (%)
73.5 (8.8)
452 (45.7)
5.6 (3.5)
273
513
77
50
36
27
13

(27.6)
(51.9)
(7.8)
(5.1)
(3.6)
(2.7)
(1.3)

510 (57.4)
234 (26.4)
144 (16.2)
113 (11.4)
11 (1.1)
46 (4.7)
165 (16.7)
50 (5.1)
3 (0.3)
14 (1.4)
13 (1.3)
9 (0.9)
36 (3.6)
4 (0.4)
50 (5.1)
605
365
19
145.2
82.7
69.9
27.2
67.6
12.8

(61.2)
(36.9)
(1.9)
(21.2)
(9.1)
(12.9)
(4.1)
(20.7)
(8.9)

160
410
356
1996.4
2357.9
89.0
139.5
862.5

(16.2)
(41.5)
(36.0)
(602.2)
(848.9)
(73.3)
(65.7)
(734.7)

24.5
29.9
28.9
1.72

(5.2)
(16.5)
(18.2)
(24.1)

Values expressed as estimated mean and standard deviation (SD) or frequency (n) and percentage (%). Where measurements were not obtained in
the full set of 989 participants, the exact number of participants for the
variable is stated in brackets under the variable name. Key: BMI: body mass
Index; CESD: Centre for Epidemiological Studies Depression; eGFR: estimated
glomerular filtration rate; MMSE: Mini Mental State Examination; TIA: transient ischaemic attack; TMT A: Trail Making Test A; TMT B: Trail Making Test
B; TMT A–B: Difference between TMT A and TMT B test scores.

was inversely associated with SBP (-0.005 ±
0.001 mmHg, p < 0.001) and DBP (-0.001 ±
0.001 mmHg, p ¼ 0.002) in fully adjusted models. No

significant associations were observed for dietary
nitrate and BP (Table 3).
Associations between sodium and nitrate intake
and impaired cognitive function
No significant associations were observed for tertiles of
urinary sodium and nitrate concentrations and for dietary sodium and nitrate intake with odds of cognitive
impairment (i.e. MMSE, TMT-A, TMT-B and TMT AB) (Table 1 of the online supplementary material).
Associations between sodium and nitrate intake
and high BP
Urinary sodium concentrations and dietary sodium
and nitrate intake were not associated with BP. For
24-hour urinary nitrate concentrations, those in tertile
2 (OR ¼ 0.57, 95%CI 0.37–0.88, p ¼ 0.01) and tertile
3 (OR ¼ 0.31, 95%CI 0.21–0.48, p < 0.001) had a
lower odds of high BP in comparison to those in tertile 1 (Table 4).
ANCOVA analysis: differences in cognitive function
and BP between groups
There were no statistically significant differences
between groups for cognitive performance (all tasks)
(Table 5 of the online supplementary material).
Statistically significant differences between groups for
both SBP (p < 0.001, Figure 1(A)) and DBP (p ¼ 0.041,
Figure 1(B)) were found in fully-adjusted models
(Table 5 of the online supplementary material). The
HNLS had significantly lower mean SBP compared to
LNLS (6.7 mmHg, 95%CI 12.4, 1.0 mmHg;
p ¼ 0.003) and LNHS (6.1 mmHg, 95%CI 11.8,
0.4 mmHg; p ¼ 0.018) groups. Similarly, the HNHS
group showed lower mean SBP compared to LNLS
(6.7 mmHg, 95%CI 11.8, 1.6 mmHg; p ¼ 0.003)
and LNHS (5.9 mmHg, 95%CI 11.1, 0.6 mmHg;
p ¼ 0.017) groups (Figure 1(A)).
Association of dietary nitrate and sodium intake with
24-hour urinary nitrate and sodium concentrations
Dietary nitrate and sodium intake assessed by FFQ
were not associated with 24-hour urinary sodium
(r ¼ 0.01, p ¼ 0.61, Figure 2(A)) and nitrate (r ¼ 0.02,
p ¼ 0.48, Figure 2(B)) concentrations, respectively.

Discussion
In this cross-sectional analysis, sodium and nitrate
intake, derived from FFQ data and measurement of
24-hour urinary concentrations, was not associated
with cognitive performance in the InCHIANTI study
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Table 2. Multiple linear regression to investigate the association between urinary and dietary measures of sodium and nitrate intake with cognitive performance.
Urinary Sodium (mmol/24 hr)
Model 1
Model 2
Dietary Sodium Intake (mg/day)
Model 1
Model 2
Urinary Nitrate (mmol/24 hr)
Model 1
Model 2
Dietary Nitrate Intake (mg/day)
Model 1
Model 2

MMSE

TMT A

TMT B

0.003 ± 0.002
p ¼ 0.120
0.001 ± 0.001
p ¼ 0.537

0.005 ± 0.009
p ¼ 0.566
0.007 ± 0.009
p ¼ 0.476

0.006 ± 0.011
p ¼ 0.554
0.009 ± 0.011
p ¼ 0.406

<0.0001 ± 0.001
p ¼ 0.539
<0.0001 ± 0.001
p ¼ 0.212

0.001 ± 0.001
p ¼ 0.304
<0.001 ± 0.001
p ¼ 0.722

<0.0001 ± 0.001
p ¼ 0.878
<0.0001 ± 0.001
p ¼ 0.988

<0.0001 ± 0.001
p ¼ 0.750
<0.0001 ± 0.001
p ¼ 0.986

0.001 ± 0.001
p ¼ 0.503
<0.0001 ± 0.001
p ¼ 0.925

0.001 ± 0.001
p ¼ 0.508
0.001 ± 0.001
p ¼ 0.208

0.001 ± 0.001
p ¼ 0.608
0.001 ± 0.001
p ¼ 0.415

0.002 ± 0.008
p ¼ 0.782
0.004 ± 0.008
p ¼ 0.693

0.006 ± 0.009
p ¼ 0.488
0.006 ± 0.009
p ¼ 0.513

Associations were explored via multiple linear regression. Results expressed as estimate and standard error. *p Value
<0.05. Models were unadjusted (model 1) and adjusted for age, sex, disease count score (stroke, CHF, MI, PD, cancer and
diabetes), medication use (drugs for acid-related disorders; diuretics for CHF or hypertension; ACE inhibitors (alone and in
combination with diuretic); organic nitrates; aldosterone antagonists (diuretics); glucocorticoids for systemic use; antiepileptic; anti-Parkinson drugs; psycholeptics: typical antipsychotics; psycholeptics: atypical antipsychotics; psycholeptics: anxiolytics; psychoanaleptics: antidepressants; drugs for dementia), BMI, Physical Activity, Total Energy Intake, Smoking,
Education, Depression, Kidney function, Blood pressure (SBP and DBP) (model 2).
Key: ACE: angiotensin-converting-enzyme; BMI: body mass index; CHF: chronic heart failure; DBP: diastolic blood pressure;
MI: myocardial infarction; MMSE: Mini Mental State Examination; PD: Parkinson’s disease; TMT A: Trail Making Test A; TMT
B: Trail Making Test B; SBP: systolic blood pressure.

Table 3. Multiple linear regression of the association sodium
and nitrate intake with blood pressure (BP).
Urinary sodium (mmol/24 hr)
Model 1
Model 2
Dietary sodium intake (mg/day)
Model 1
Model 2
Urinary nitrate (mmol/24 hr)
Model 1
Model 2
Dietary nitrate intake (mg/day)
Model 1
Model 2

SBP

DBP

0.008 ± 0.011
p ¼ 0.542
0.010 ± 0.011
p ¼ 0.371

0.005 ± 0.005
p ¼ 0.329
0.005 ± 0.005
p ¼ 0.262

 <0.001 ± 0.001
p ¼ 0.631
0.001 ± 0.001
p ¼ 0.638

<0.0001 ± 0.001
p ¼ 0.968
0.0001 ± 0.001
p ¼ 0.894

0.005 ± 0.001
p¼ <0.001
0.005 ± 0.001
p¼ <0.001

0.001 ± 0.001
p ¼ 0.002
0.001 ± 0.001
p ¼ 0.002

0.003 ± 0.010
p ¼ 0.741
0.004 ± 0.010
p ¼ 0.678

0.005 ± 0.004
p ¼ 0.188
0.005 ± 0.004
p ¼ 0.214

Associations were explored via multiple linear regression. Results
expressed as estimate and standard error. Models were unadjusted
(model 1) and adjusted for age, sex, disease count score (stroke, CHF, MI,
PD, cancer and diabetes), BMI, Physical Activity, Total Energy Intake,
Smoking, Kidney function, medication use (drugs for acid-related disorders; diuretics for CHF or hypertension; ACE inhibitors (alone and in combination with diuretic); organic nitrates; aldosterone antagonists
(diuretics); glucocorticoids for systemic use) (model 2).
Key: BMI: body mass index; CHF: chronic heart failure; DBP: diastolic blood
pressure; MI: myocardial infarction; PD: Parkinson’s disease; SBP: systolic
blood pressure

population. In addition, no significant association was
found with BP for dietary nitrate intake measured by

FFQ and both measures of sodium intake (24-hour
urine and FFQ). However, higher concentrations of
24-hour urinary nitrate were associated with lower
systolic and diastolic BP values, indicating that objective biomarkers of nitrate intake may be more sensitive
measures of dietary exposure to detect significant
associations with health outcomes. This study also
explored the interactive effects between sodium and
nitrate 24-hour urinary nitrate concentrations on BP
and cognitive performance. While no significant dietary interactions were found with cognitive performance, there was a significant association of the high
nitrate groups (HNLS and HNHS), independent of
sodium intake, on mean systolic and diastolic BP and
a lower odds of high BP in both groups with higher
24-hour urinary nitrate concentrations.
Recent observational studies have explored the
association between sodium intake and cognitive performance and cardiovascular outcomes to find mixed
results (He and MacGregor 2018; Kendig and Morris
2019; Mohan et al. 2020). A study by Lelli et al, (Lelli
et al. 2018) conducted in the InCHIANTI population
(n ¼ 920) found no association between 24-hour urinary sodium excretion and 9-year incidence of cardiovascular diseases (adjusted risk ratio 0.96, 95% CI
0.90–1.02). Conversely, a smaller study (n ¼ 119)
reported a significant association between higher
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Table 4. Logistic regression of the association between
sodium and nitrate intake and risk of high blood pressure.
SBP
Urinary sodium (mmol/24 hr) Model 1
Low (n ¼ 279)
1.00
(0–90.3)
(Reference)
Medium (n ¼ 313)
1.223 (0.87–1.73)
(90.3–131.6)
p ¼ 0.252
High (n ¼ 321)
0.981 (0.70–1.37)
(131.6 and above)
p ¼ 0.911
Model 2
Low (n ¼ 279)
1.00
(0–90.3)
(Reference)
Medium (n ¼ 313)
1.15 (0.80–1.66)
(90.3–131.6)
p ¼ 0.458
High (n ¼ 321)
0.93 (0.67–1.34)
(131.6 and above)
p ¼ 0.721
Dietary sodium Intake (mg/day) Model 1
Low (n ¼ 309)
1.00
(0–1901.4)
(Reference)
Medium (n ¼ 346)
1.286 (0.93–1.78)
(1901.4–2600.5)
p ¼ 0.132
High (n ¼ 334)
1.095 (0.78–1.55)
(2600.5 and above)
p ¼ 0.607
Model 2
Low (n ¼ 309)
1.00
(0–1901.4)
(Reference)
Medium (n ¼ 346)
1.35 (0.93–1.97)
(1901.4–2600.5)
p ¼ 0.115
High (n ¼ 334)
1.14 (0.72–1.82)
(2600.5 and above)
p ¼ 0.563
Urinary nitrate (mmol/24 hr) Model 1
Low (n ¼ 303)
1.00
(0–502.3)
(Reference)
Medium (n ¼ 298)
0.656 (0.46–0.94)
(502.4–894.8)
p ¼ 0.021
High (n ¼ 294)
0.416 (0.29–0.59)
(894.9 and above)
p¼ <0.0001
Model 2
Low (n ¼ 303)
1.00
(0–502.3)
(Reference)
Medium (n ¼ 298)
0.57 (0.37–0.88)
(502.4–894.8)
p ¼ 0.011
High (n ¼ 294)
0.31 (0.21–0.48)
(894.9 and above)
p¼ <0.0001
Dietary nitrate intake (mg/day) Model 1
Low (n ¼ 319)
1.00
(0.00–502.3)
(Reference)
Medium (n ¼ 325)
1.028 (0.73–1.43)
(502.4–894.8)
p ¼ 0.869
High (n ¼ 329)
0.951 (0.69–1.32)
(894.9 and above)
p ¼ 0.761
Model 2
Low (n ¼ 319)
1.00
(0.00–502.3)
(Reference)
Medium (n ¼ 325)
1.07 (0.76–1.52)
p ¼ 0.694
(502.4–894.8)
High (n ¼ 329)
1.00 (0.71–1.42)
(894.9 and above)
p ¼ 0.979

DBP
1.00
(Reference)
0.919 (0.65–1.29)
p ¼ 0.627
0.885 (0.63–1.24)
p ¼ 0.481
1.00
(Reference)
0.90 (0.63–1.31)
p ¼ 0.597
0.89 (0.62–1.28)
p ¼ 0.540
1.00
(Reference)
1.076 (0.78–1.49)
p ¼ 0.659
0.904 (0.65–1.26)
p ¼ 0.552
1.00
(Reference)
1.01 (0.70–1.46)
p ¼ 0.958
0.84 (0.53–1.35)
p ¼ 0.482
1.00
(Reference)
0.795 (0.58–1.10)
p ¼ 0.166
0.769 (0.56–1.06)
p ¼ 0.113
1.00
(Reference)
0.75 (0.52–1.10)
p ¼ 0.140
0.68 (0.47–1.01)
p ¼ 0.054
1.00
(Reference)
1.057 (0.76–1.47)
p ¼ 0.739
0.996 (0.72–1.38)
p ¼ 0.981
1.00
(Reference)
1.11 (0.79–1.57)
p ¼ 0.549
0.97 (0.69–1.38)
p ¼ 0.886

Associations were explored via logistic regression. *Significantly
(p < 0.05) higher risk of hypertension compared with the lowest tertile
of urinary sodium/dietary sodium/urinary nitrate/dietary nitrate.
Hypertension classified using European Society of Cardiology ESC guidelines – normal SBP < ¼139mmHg: Hypertension > ¼140mmHg; Normal
DBP < ¼89mmHg: Hypertension > ¼90mmHg). Models were unadjusted
(model 1) and adjusted for age, sex, disease count score (stroke, CHF,
MI, PD, cancer and diabetes), BMI, Physical Activity, Total Energy Intake,
Smoking, Kidney function, medication use (drugs for acid-related disorders; diuretics for CHF or hypertension; ACE inhibitors (alone and in
combination with diuretic); organic nitrates; aldosterone antagonists
(diuretics); glucocorticoids for systemic use) (model 2). Key: BMI: body
mass index; CHF: chronic heart failure; DBP: diastolic blood pressure;
MI: myocardial infarction; PD: Parkinson’s disease; SBP: systolic
blood pressure.

urinary sodium excretions with lower MMSE scores
(Afsar 2013). Other studies have evaluated associations
between cognitive performance and sodium intake
using data derived from FFQs. For example, a longitudinal study among community dwelling older adults
(Rush et al. 2017) reported a significant association
between lower dietary sodium intake with poorer performance on tests of global (MMSE) and executive
(Trails B) cognitive function after controlling for age,
sex, and education. The NuAGE study (Fiocco et al.
2012) investigated the association of physical activity,
sodium intake and cognitive function and found that
a higher sodium intake was associated with a greater
3-year decline in global cognitive function, but only in
individuals with low physical activity levels. Nowak
et al., (Nowak et al. 2018) evaluated the associations
of dietary sodium, potassium and ratio of sodium:
potassium intake with cognitive decline among community-dwelling older adults from the Health, Ageing
and Body Composition (ABC) study. The study
showed that higher sodium: potassium intake, but not
sodium or potassium intake alone, was associated
with decline in cognitive function, with no associations observed with micro- and macro-structural brain
MRI indices. Finally, a prospective follow up study
among 6,426 cognitively normal older women from
the Women’s Health Initiative Memory Study
(WHIMS) (Haring et al. 2016) demonstrated that
sodium intake did not modify the risk for cognitive
decline in women with hypertension or receiving antihypertensive medication.
Recent observational studies have explored the
association of urinary nitrate with cardiovascular outcomes and cognitive performance. Smallwood et al.,
(Smallwood et al. 2017) showed in the InCHIANTI
study a lower diastolic (-1.9 mm Hg) and systolic
(-3.4 mm Hg) BP in participants with urinary nitrate
excretion greater than 2 mmol. In addition, two independent analyses conducted in the NHANES dataset
found that urinary nitrate concentrations in spot samples were associated with a lower prevalence of hypertension, stroke and congestive heart failure (Mendy
2018; Wu et al. 2020). These findings are consistent
with the results presented here, with significant associations of 24-hour urinary nitrate with systolic BP but
this was not seen in analyses with self-reported dietary
nitrate derived from the FFQ.
A cross-sectional study among the NHANES cohort
(Pereira et al. 2021) found that urinary nitrate concentrations were not associated with cognitive performance which is consistent with the results reported in
this paper.
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Table 5. Logistic regression of the association between
sodium and nitrate intake groups and risk of high
blood pressure.
Model 1
Groups 4: LNHS
(n ¼ 207)
Group 1: HNLS
(n ¼ 205)
Group 2: HNHS
(n ¼ 205)
Group 3: LNLS
(n ¼ 205)
Model 2
Groups 4: LNHS
(n ¼ 207)
Group 1: HNLS
(n ¼ 205)
Group 2: HNHS
(n ¼ 205)
Group 3: LNLS
(n ¼ 205)

SBP

DBP

1.00
(Reference)
0.49 (0.32–0.75)
p ¼ 0.001
0.48 (0.32–0.78)
p ¼ 0.001
0.83 (0.53–1.29)
p ¼ 0.829

1.00
(Reference)
0.95 (0.63–1.43)
p ¼ 0.806
0.93 (0.62–1.40)
p ¼ 0.725
1.15 (0.77–1.73)
p ¼ 0.489

1.00
(Reference)
0.49 (0.32–0.76)
p ¼ 0.001
0.49 (0.32–0.77)
p ¼ 0.002
0.85 (0.54–1.35)
p ¼ 0.504

1.00
(Reference)
1.05 (0.68–1.64)
p ¼ 0.814
0.94 (0.61–1.46)
p ¼ 0.782
1.18 (0.77–1.82)
p ¼ 0.435

Associations were explored via logistic regression. *Significantly (p < 0.05)
higher risk of hypertension compared with those in groups 2, 3 and 4
(reference). Hypertension classified using European Society of Cardiology
ESC guidelines – Normal SBP < ¼139mmHg: Hypertension
> ¼140mmHg; Normal DBP < ¼89mmHg: Hypertension > ¼90mmHg)
Models were unadjusted (model 1) and adjusted for age, sex, disease
count score (stroke, CHF, MI, PD, cancer and diabetes), BMI, Physical
Activity, Total energy Intake, Smoking, Kidney function and medication
use (drugs for acid-related disorders; diuretics for CHF or hypertension;
ACE inhibitors (alone and in combination with diuretic); organic nitrates;
aldosterone antagonists (diuretics); glucocorticoids for systemic use)
(model 2).
Key: BMI: body mass index; CHF: chronic heart failure; DBP: diastolic blood
pressure; HNLS: high nitrate low sodium; HNHS: high nitrate high sodium;
LNLS: low nitrate low sodium; LNHS: low nitrate high sodium; MI: myocardial infarction; PD: Parkinson’s disease; SBP: systolic blood pressure.

The interaction between dietary sodium and nitrate
24-hour urinary concentrations produced interesting
but also unexpected results. Both high-nitrate groups
were associated with lower BP values and results were
not modified by sodium concentrations. We also
tested whether significant interactive associations were
observed using dietary sodium and nitrate intake data
from the FFQs but results were not significant
(Supplementary Material).
These findings certainly merit a discussion on the
sensitivity of the dietary assessment methods for both
sodium and nitrate. We have showed in this population a lack of association between FFQ measures of
intake for both nitrate and sodium and 24-urinary
concentrations. The association of 24-hour urinary
nitrate concentrations with lower BP readings are
aligned with results found in previous studies, which
seems to indicate a greater sensitivity of objective biomarkers of nitrate intake to ascertain associations with
relevant health outcomes. The lack of a significant
association of the FFQ method could be partly due to
its ability to capture long-term exposure to dietary
factors, which may not be ideal in cross-sectional
studies to evaluate associations with health outcomes,
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especially when both exposures and outcomes may be
characterised by short biological half-lives and prone
to significant variability between measurements (Satija
et al. 2015; Bennett et al. 2017). Furthermore, sodium
intake could be underestimated by FFQ assessments,
as it may not accurately capture when salt is added to
meals, whereas nitrate intake could be overestimated
as individuals tend to misjudge their intake of vegetables when questioned (Cobb et al. 2014).
Measurements of dietary exposure in 24-hour urinary
samples, if collected alongside the measurements of
the outcome variables, may provide a more accurate
measure of dietary exposure to test associations with
health outcomes. Repeated 24-hour dietary recalls
may provide a superior proxy of dietary intake if collected alongside outcome measurements and collection
of biological samples. However, FFQ may represent a
more sensitive method to investigate associations in
longitudinal analyses as they might be better proxy of
a life-long, typical dietary exposure in an individual
and hence more suitable to investigate associations
over prolonged follow up periods. These important
methodological questions require further investigation
in carefully designed validation studies.
A discussion of the biological mechanisms that
may explain the greater association of dietary nitrate
with BP outcomes compared to sodium intake is relevant. Both sodium and nitrate influence NO production and affect endothelial integrity and vascular tone
(Oberleithner et al. 2007; DeMartino et al. 2019).
Their respective roles are however contrasting as an
increase in nitrate intake determines, via a two-step
reduction process, the formation of nitrite first (via
facultative anaerobic bacteria on the dorsal surface of
the tongue) and then conversion into NO (stomach or
peripheral circulation), which increases the dephosphorylation of myosin lighter chains and Ca2þ reuptake into the sarcoplasmic reticulum leading to
vaso-relaxation (Chen et al. 2008). On the other hand,
the association of sodium intake with BP seems to
have a J-shaped association as both low and high
sodium intakes may have negative effects on mediators of vascular resistance and fluid homeostasis (i.e.
autonomic regulation, renin-angiotensinin-aldosterone
system, oxidative stress, extracellular matrix remodelling), which may explain the contrasting associations
between dietary sodium intake and cardiovascular
outcomes found in the literature (Edwards and
Farquhar 2015). While the role of low sodium intake
was not explored in this analysis, it is still unexpected
the lack of association between high sodium intake
and BP and the sodium-independent, protective roles
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of high dietary nitrate intake in this population. It is
conceivable that the biological effects of the highsodium diets may have been influenced by several
factors affecting sodium-handling in individuals,
including salt-sensitivity, genetic polymorphisms and
nutrient-nutrient interactions (i.e. potassium or magnesium) (Morrison and Ness 2011). The physiological
mechanisms involved in the control of vascular
homeostasis during the co-ingestion of nitrate (normal
and high intakes) and sodium (low, normal and high)
need investigation in carefully controlled feeding studies.
Strengths and limitations
This is the first study to investigate the interactive
effects of sodium and nitrate intake, using both biomarkers and FFQ derived measures of intake, with
cognitive performance and BP. The inclusion of a
large population-based sample with validated and
standardised protocols for 24-hour urine collections,
self-reported dietary assessment, measurement of cognitive performance and BP, combined with a structured statistical approach to model testing and
adjustment, enhance the robustness of the results.
However, this is an ageing cohort recruited from the
Chianti region of Italy, and generalisability to other
settings needs to be established. The cross-sectional
design is an important limitation of our study, as
causality of the associations cannot be determined.
Some methodological issues to be considered in interpreting our findings also include potential measurement error in the self-reported dietary data.
Additionally, we cannot rule out the effects of residual
confounding on the analyses. It is important to consider the limitations surrounding the cognitive data
used in this study. Although global cognition was
measured via MMSE, frontal lobe function evaluation
was limited to TMT-A and TMT-B due to data availability. It cannot be excluded that subtle deficits might
have been detected with more extensive neuropsychological testing (Vinciguerra et al. 2020). It is important
to note the limitations surrounding collection of 24hour urinary samples at one time-point. Finally, the
contribution of drinking water to the total dietary
nitrate intake was not available in our database.
However, nitrate intake from water accounts for about
5-15% of total nitrate intake (Ward et al. 2018) and
there is no indication of a systematic difference in
water intake between subjects; hence, the lack of
adjustment for nitrate in drinking water is unlikely to
modify our results.

Conclusions
Urinary nitrate excretion was associated with reduced
BP among the InCHIANTI study population and the
results were independent of dietary sodium intake.
However, this result requires further confirmation in
longitudinal studies and carefully controlled physiological investigations. Similarly, the lack of association
of dietary sodium and nitrate intake with cognitive
function and dementia needs further testing in longitudinal analysis with prolonged follow-up time to be
able to detect diet-driven changes in cognitive trajectories. The results confirm the potential role of nitrate
as an important cardiovascular protective component
of the diet, which may account for some of the cardiovascular benefits associated with adherence to
healthy dietary patterns such as the Mediterranean
Diet or Dietary Approach to Stop Hypertension
(DASH diet).
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